Therapeutic Horizon in Multiple Myeloma: Analysis of the Emerging Landscape of Clinical Trials

Marina Alacoque Rodrigues, Cristiane Aparecida Menezes de Pádua, Paula Lana de Miranda Drummond, Jéssica Soares Malta, Adriano Max Moreira Reis · 2026

Read Therapeutic Horizon in Multiple Myeloma: Analysis of the Emerging Landscape of Clinical Trials by Marina Alacoque Rodrigues, Cristiane Aparecida Menezes de Pádua, Paula Lana de Miranda Drummond, Jéssica Soares Malta, Adriano Max Moreira Reis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13354661.txt.

Description

Marina Alacoque Rodrigues and co-authors map the clinical trial landscape for multiple myeloma over a decade, in a 2026 study. New therapies have extended survival and grown more targeted. The disease, a blood cancer of plasma cells, remains incurable. Knowing where trials are heading helps patients and planners alike.

Registries and industry intelligence supplied the trial records. Active and completed studies from 2014 to 2024 were included. Both new diagnoses and relapsed disease were covered. Trend models estimated yearly percent changes in trial activity. Breakdowns by phase, drug type, and design reveal the field's direction. Funders can spot crowded and neglected niches. The horizon scan is a planning document for the next decade.

Catalog record

CREATORMarina Alacoque Rodrigues, Cristiane Aparecida Menezes de Pádua, Paula Lana de Miranda Drummond, Jéssica Soares Malta, Adriano Max Moreira Reis
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13354661

Browse the full library · About the Tower of Babel